FDA-Inspected Site

Duke Clinical Research Institute

5 FDA inspections are on record for Duke Clinical Research Institute in Durham, United States.

Clean· No action indicated

Durham, United States · Last updated July 10, 2026

Overview

  • 5 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2019-01-17.

At a glance

Inspections

5

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
7 Jan 2019 – 17 Jan 2019Human DrugsClean
26 Oct 2015 – 4 Nov 2015Human Drugs483View 483 →
10 Sep 2013 – 19 Sep 2013Medical Devices & Rad HealthClean
24 Aug 2012Not recordedClean
23 Sep 2008Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

4 Nov 2015
21 CFR 312.50

Ensuring compliance with plan and protocol

Cited by Betsy C Galliher, Tracy R Ball

4 Nov 2015
21 CFR 312.50

General responsibilities of sponsors

Cited by Betsy C Galliher, Tracy R Ball

Investigators

FDA investigators tied to this site in the record.

Barbara M Frazier1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 312.50Cited across public-safe Form 483 observations2x

Full site report

Get the verbatim findings behind Duke Clinical Research Institute's 1 Form 483

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat